Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000088863

Apexbio Technology LLC (±)-5'-Chloro-5'-deoxy-ENBA 103626-26-2 50mg
SDP

Catalog No. 5000088863
Encompass_Preferred

racemic Baclofen -5p-Chloro-5p-deoxy-ENBA is a small-molecule agonist targeting the adenosine A1 receptor It is designed to activate adenosine A1 receptor-mediated signaling thereby regulating neuroprotective cardioprotective and nociceptive pathways racemic Baclofen -5p-Chloro-5p-deoxy-ENBA exerts its biological activity primarily through activation of the adenosine A1 receptor In animal models administration of this compound alleviates inflammatory and neuropathic pain behaviors by modulating both peripheral and central pain pathways and influencing glial cell responses without affecting motor coordination or cardiovascular function In experimental models of Parkinson s disease it reduces L-DOPA-induced abnormal involuntary movements through modulation of striatonigral GABAergic neurotransmission Based on these pharmacological properties racemic Baclofen -5p-Chloro-5p-deoxy-ENBA holds research potential in pain management and movement disorders

Catalog No. 50-000-88863 Supplier Apexbio Technology LLC Supplier No. B743550
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

racemic Baclofen -5p-Chloro-5p-deoxy-ENBA is a small-molecule agonist targeting the adenosine A1 receptor It is designed to activate adenosine A1 receptor-mediated signaling thereby regulating neuroprotective cardioprotective and nociceptive pathways racemic Baclofen -5p-Chloro-5p-deoxy-ENBA exerts its biological activity primarily through activation of the adenosine A1 receptor In animal models administration of this compound alleviates inflammatory and neuropathic pain behaviors by modulating both peripheral and central pain pathways and influencing glial cell responses without affecting motor coordination or cardiovascular function In experimental models of Parkinson s disease it reduces L-DOPA-induced abnormal involuntary movements through modulation of striatonigral GABAergic neurotransmission Based on these pharmacological properties racemic Baclofen -5p-Chloro-5p-deoxy-ENBA holds research potential in pain management and movement disorders

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.